No Data
No Data
ZYUS Life Sciences Corp. Brief: Says Cannabis Drug License Enables It to Expand Its Clinical Research Activities by Manufacturing Drugs Containing Cannabis in Canada
09:08 AM EDT, 06/04/2024 (MT Newswires) -- ZYUS Life Sciences Corp. Brief: Says Cannabis Drug License Enables It to Expand its Clinical Research Activities by Manufacturing Drugs Containing Cannabis i
ZYUS Life Sciences Receives Cannabis Drug License From Health Canada
ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9
ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
Calian Group and MDA Brief: Calian Says "Strengthens Nuclear Capability" With Acquisition of MDA Ltd. Nuclear Assets
05:16 PM EST, 03/05/2024 (MT Newswires) -- Calian Group and MDA Brief: Calian Says "Strengthens Nuclear Capability" with Acquisition of MDA Ltd. Nuclear Assets
Calian Group Brief: Says Won Contract to Support Clinical Trial for ZYUS Life Sciences' Lead Drug Product Candidate
04:37 PM EST, 02/20/2024 (MT Newswires) -- Calian Group Brief: Says Won Contract to Support Clinical Trial for ZYUS Life Sciences' Lead Drug Product Candidate